Q4 2024 · 13F-HR
JOHNSON & JOHNSON (JNJ)holdings as filed
Filed 2025-02-13 · accession 0000904454-25-000124
$386.1M
Reported value
20
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74366E102 | PTGX | Protagonist Therapeutics Inc. | $94.5M | 24.5% | 2,449,183 | Common | SHARED |
| 126638105 | CVRX | CVRx, Inc. | $52.0M | 13.5% | 4,103,430 | Common | SHARED |
| 75383L102 | RAPP | Rapport Therapeutics, Inc. | $44.3M | 11.5% | 2,498,051 | Common | SHARED |
| G59665102 | MGTX | MeiraGTx Holdings plc | $40.4M | 10.5% | 6,641,064 | Common | SHARED |
| 21217B100 | CTNM | Contineum Therapeutics Inc. | $29.0M | 7.51% | 1,979,173 | Common | SHARED |
| 74276L105 | PRCT | Procept BioRobotics Corporation | $28.8M | 7.46% | 357,939 | Common | SHARED |
| 52490G102 | LEGN | Legend Biotech Corporation | $26.5M | 6.86% | 814,586 | Common | SHARED |
| 640979100 | NMRA | Neumora Therapeutics, Inc. | $19.6M | 5.08% | 1,849,445 | Common | SHARED |
| 98401F105 | XNCR | Xencor, Inc. | $17.2M | 4.45% | 748,062 | Common | SHARED |
| 63009J107 | NBTX | Nanobiotix S.A. | $16.1M | 4.18% | 5,623,816 | Common | SHARED |
| 31189P102 | FATE | Fate Therapeutics, Inc. | $5.6M | 1.44% | 3,379,064 | Common | SHARED |
| 04280A100 | ARWR | Arrowhead Pharmaceuticals, Inc. | $4.7M | 1.21% | 247,598 | Common | SHARED |
| 75120L100 | — | Rallybio Corporation | $3.5M | 0.90% | 3,636,363 | Common | SHARED |
| 929033108 | — | Vor Biopharma, Inc. | $1.2M | 0.31% | 1,074,658 | Common | SHARED |
| M70700105 | NNOX | Nano-X Imaging Ltd. | $1.1M | 0.30% | 158,852 | Common | SHARED |
| 34385P108 | LAB | Standard BioTools Inc | $545,942 | 0.14% | 311,967 | Common | SHARED |
| 55083R104 | — | Lyell Immunopharma Inc. | $526,923 | 0.14% | 823,317 | Common | SHARED |
| 007002108 | TORCEUR | Adicet Bio, Inc. | $350,622 | 0.09% | 364,472 | Common | SHARED |
| 09090D103 | — | BiomX Inc. | $70,722 | 0.02% | 96,866 | Common | SHARED |
| 81727U105 | SENS1GBP | Senseonics Holdings, Inc. | $28,589 | 0.01% | 54,621 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.